Ashutosh Mahapatra, MD

Join @brainplumberMD on Wednesday, June 11 at 4:00 PM ET for "Medium and Distal Vessel Occlusions: Utilizing Microfabricated Technology to Optimize Results". Thank you to @ScientiaInc for sharing this webinar with our members. Register: register.gotowebinar.com/register/35889…

@chenjared @cvsection @SNISinfo @LINNConline @StrokeAHA_ASA @NeurosurgUTH @UTHealthStroke If proven good collaterals, including asymptomatic patient with hypotension challenge and normal perfusion workup, could do deconstruction as well. I prefer a reconstructive approach when possible, though, as you did. Nice work!

70F with left side strokes/TIAs. Good cross flow from contralateral ICA through ACommA. What is your approach in management? Reconstruction? Deconstruction? Medical management? @cvsection @SNISinfo @LINNConline @StrokeAHA_ASA @NeurosurgUTH @UTHealthStroke

🌍 SEAL IT IDE Trial Update 🌍 Cleveland Clinic hits 10 enrollments, the site that leads the SEAL IT trial! Today’s 70th case was enrolled by Dr. Shazam Hussain, with contributions this week from Dr. Ashutosh Mahapatra. Thank you, Cleveland Clinic team! #SEALIT #Galaxy

Fantastic joint @wfitn_ny @svinsociety session with amazing speakers on the most pressing topics of acute stroke endovascular care: tandem occlusions, large core, MeVO and low NIHSS. #WFITN2024 #SVIN

@UChicago_Neuro Congrats @TareqKass. Dominating Chicago NIR!

The Neurology Department is proud to announce New Clinical Research Leadership! As we enter the new academic year, we are excited to announce clinical leadership roles within the department. In partnership with Dr. Lakshmi Warrior, Vice Chair of Clinical Operations, these leaders will develop a system-level approach to building and expanding key programs in the department and health system. Not only will they chart new directions but these will foster their own leadership development and progress as valued faculty in the department. Tareq Kass-Hout, MD, is named Chief Innovation, Technology, and Business Officer. Dr. Kass-Hout has already been playing an important role in identifying external partnership opportunities and connecting with various hospitals to bridge partnerships with our department and clinicians. This position will continue to build upon that role as the department looks to build external programmatic opportunities regionally, nationally, and internationally. Dr. Kass will also serve as a key advisor to the service line and our external partners on technological patient care innovations in neurosciences. He will partner with department faculty in our various clinical sections to understand their technological needs and help to evaluate investment opportunities in new technologies.

@eytanraz Thanks for the link. Great work! Looking forward to trying some of this out in my practice.

@brainplumberMD We tried to put a few tricks to get the most out of 3D, down in this paper: jnis.bmj.com/content/neurin… The most important ones are to use "micro" feature, reconstruct in small FOV, have patient well still (GA and apnea preferably).

MIP recon from a 3D-DSA micro acquisition. Important anatomical points 🍌🍌🍌on this short video: "double" ACom, origin and variable dominance of Heubner arteries (compare side to side), subcallosal supply to the hypothalamus.

Only a week away! Don’t miss the opportunity to learn about the latest and greatest in Cerebrovascular Disease at the @CleClinicMD @ClevelandClinic Innovations conference on June 18-19! Detailed program, and in-person or virtual attendance options at ccfcme.org/IICC

Our most recent study shows that CNS vasculitis can be predicted by quantitative vessel wall MRI metrics in addition to CSF pleocytosis and clinical features when brain biopsy is unobtainable or inconclusive. @shazamhussain @CT_LP_MRI @DrYFarag neurology.org/doi/10.1212/CP…

After suffering an ischemic stroke, Roy James, 70, became the first patient in Houston to be enrolled in the THUNDER clinical trial led by Ashutosh Mahapatra, MD, with @UTHNeuro. Watch his full story here: go.uth.edu/Fox26_RoyJames

A huge thanks to our esteemed faculty Drs. John Chaloupka, Matt Fiesta, @OrlandoDiazMD, @neurointervener, @brainplumberMD, @robertereplogle, @SunilAShethMD, and @vellimana & to the attendees who helped make the Houston FLIP Navigating Complications Course a resounding success!🧠

It’s that time of year! Program is stellar- back to 2 days and packed with many areas of controversy and the latest innovations in the Cerebrovascular and Neurocritical Care fields! Incl. mini-symposium on CAA-and virtual attendance for trainees is free! ccfcme.org/IICC

Impressive stability from #BMX81 in a tortuous left carotid stenting case from transradial approach.

I had some thoughts… on death. We are overdue for a reconsideration of mortality vs disability in our new large core stroke world. ahajournals.org/doi/10.1161/SV…

our stellar faculty lineup. Join us on May 9th & 10th with Drs. John Chaloupka, Matthew Fiesta, @OrlandoDiazMD, @neurointervener, @brainplumberMD, @robertereplogle, @SunilAShethMD, & @vellimana. Hurry, only 3 spots left! #FellowsLeapingIntoPractice cvent.me/LVLBoE

Subdural hematoma layers as shown in post nBCA dynaCT. Graph from jnis.bmj.com/content/13/5/4…

@eytanraz Do you find similar appearance with Onyx-18? In my recent practice, I feel like I get better membrane penetration with dilute NBCA. Awesome picture here.

#BANANA2024 — in-person (only) neuroangio.org based 3-day comprehensive course on practical neurovascular anatomy and intervention will take place October 14-16 2024 in New York City. Stay tuned!

"🚨 New Research Alert! 🚨 Administering calcium to patients in cardiac arrest could lead to worse outcome ⚠️

1/Talk about twisting your back! Do spine vascular lesions make your brain feel as tangled as the dilated vessels you see? Want some information on malformations? Here’s a thread on spine vascular anatomy to give you durable knowledge on dural arteriovenous fistulas (dAVF)